Proceedings of the 14th European immunogenicity platform open symposium on immunogenicity of biopharmaceuticals
Biologics have revolutionized disease management in many therapeutic areas by addressing unmet medical needs and overcoming resistance to standard-of-care treatment in numerous patients. However, the development of unwanted immune responses directed against these drugs, humoral and/or cellular, can...
Saved in:
Main Authors: | Sophie Tourdot, Daniel Baltrunkonis, Sofie Denies, Viswanath Devanarayan, Joanna Grudzinska-Goebel, Arno Kromminga, Gregor P. Lotz, Laurent Malherbe, Lydia Michaut, Karin N. Weldingh, Joao A. Pedras-Vasconcelos, Laura. I. Salazar-Fontana, Sebastian Spindeldreher, Zuben Sauna, Veerle Snoeck, Daniela Verthelyi, Daniel Kramer |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2324801 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Posttranslational Modifications and the Immunogenicity of Biotherapeutics
by: Roy Jefferis
Published: (2016-01-01) -
Analysis and Characterization of the Immunogenicity of Rhoptry Protein 18
by: Masoud Foroutan, et al.
Published: (2025-02-01) -
Immunogenic Targets for Specific Immunotherapy in Multiple Myeloma
by: Lu Zhang, et al.
Published: (2012-01-01) -
Establishing endotoxin limits to enhance the reliability of in vitro immunogenicity risk assessments
by: Yun Hee Jeong, et al.
Published: (2025-12-01) -
Therapeutic proteins immunogenicity: a peptide point of view
by: Feliciana Real-Fernandez, et al.
Published: (2023-10-01)